Major depressive disorder (MDD) is a complex psychiatric condition with strong genetic predisposition. The association of MDD with genetic polymorphisms, such as Val66Met (rs6265), in the brain derived neurotrophic factor (BDNF), have been reported in many studies and the results were conflicting. In this study, we performed a systematic literature search and conducted random-effects meta-analysis to evaluate genetic variants inBDNFwith MDD. A gene-based analysis was also conducted to investigate the cumulative effects of genetic polymorphisms inBDNF. A total of 28 studies from 26 published articles were included in our analysis. Meta-analysis yielded an estimated odds ratio (OR) of 0.96 (95% CI: 0.89–1.05;P= 0.402) for Val66Met (rs6265), 0.83 (95% CI: 0.67–1.04;P= 0.103) for 11757C/G, 1.16 (95% CI: 0.74–1.82;P= 0.527) for 270T/C, 1.03 (95% CI: 0.18–5.75;P= 0.974) for 712A/G and 0.98 (95% CI: 0.85–1.14;P= 0.831) for rs988748. The gene-based analysis indicated thatBDNFis not associated with MDD (P> 0.21). Our updated meta- and novel gene-based analyses provide no evidence of the association ofBDNFwith major depression.